Avanos Medical (AVNS) Cash & Current Investments (2013 - 2026)

Avanos Medical has reported Cash & Current Investments for 14 years, with the latest figure at $65.6 million in Q1 2026.

• Quarterly Cash & Current Investments fell 32.37% year-over-year to $65.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.6 million (down 32.37% YoY) and the FY2025 annual result came in at $89.8 million, down 16.62% from the prior year.
• Cash & Current Investments fell to $65.6 million in Q1 2026 per AVNS's latest filing, from $89.8 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $127.7 million in Q4 2022 and troughed at $65.6 million in Q1 2026.
• A 5-year average of $94.5 million and a median of $92.2 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2025 and 2026: Cash & Current Investments grew 27.97% in 2025, then tumbled 32.37% in 2026.
• Over 5 years, Cash & Current Investments stood at $127.7 million in 2022, then plunged by 31.32% to $87.7 million in 2023, then rose by 22.81% to $107.7 million in 2024, then declined by 16.62% to $89.8 million in 2025, then decreased by 26.95% to $65.6 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $65.6 million, $89.8 million, and $70.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.